Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
S.CadoreE
The article states these apply regardless of which pathway someone is considering
How it works Start your next chapter with physician-guided care, built for real results
In November 2023, the rate of discontinuations due to medication availability peaked at 14.6%
In exchange for preferred formulary positioning and presumably favorable pricing negotiated on behalf of their plan sponsors CVS Caremark moved tirzepatide to non-formulary status
Last reviewed: May 29, 2026 Last updated: May 29, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
US$ 26.36
US$ 28.07
US$ 20.79
